Home
>
ipos-overview
Proposed Symbol | WSTNU |
---|---|
Company Name | Westin Acquisition Corp |
Exchange | |
Share Price | $ |
Employees | 2 (as of 07/23/2025) |
Status | |
Shares Offered | |
Offer amount | $57,500,000 |
Shares Over Alloted | |
Company Address | SUITE 1165-L 3 COLEMAN STREET #03-24 SINGAPORE 179804 |
Company Phone | 65 9488 4425 |
Company Website | www.innocanpharma.com |
CEO | Kok Peng Na |
State of Inc | |
Fiscal Year End | 06-30 |
Total Offering Expense | $680,000.00 |
Shareholder Shares Offered | |
Shares Outstanding | 7,020,000 |
Lockup Period (days) | 180 |
Lockup Expiration | |
Quiet Period Expiration | |
CIK | 0002076192 |
DealId | 1343167-114669 |
We are a blank check company incorporated in the Cayman Islands on June 3, 2025 as an exempted company with limited liability (meaning that our public shareholders have no liability, as shareholders of our company, for the liabilities of our company over and above the amount paid for their shares). We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities, which we refer to as a “target business.” Our efforts to identify a prospective target business will not be limited to a particular geographic location. We do not have any specific business combination under consideration and we have not (nor has anyone on our behalf), directly or indirectly, contacted any prospective target business or had any substantive discussions, formal or otherwise, with respect to such a transaction. Additionally, we have not engaged or retained any agent or other representative to identify or locate any suitable acquisition candidate, to conduct any research or take any measures, directly or indirectly, to locate or contact a target business. We will not undertake our initial business combination with any company being based in or having the majority of the company’s operations in Greater China (which includes, solely for the purpose of this prospectus Hong Kong, Taiwan and Macau). All of our management are located outside of mainland China. Our management team is led by Mr. Kok Peng Na, our chairman and chief executive officer, who has almost 25 years of combined experience in cross-border mergers and acquisitions, capital raising, deal-making and investment. Our mission is to maximize shareholder value by identifying an acquisition target with significant growth prospects. The breadth and depth of our management team’s experience empower us to adeptly identify, thoroughly assess, and strategically structure transactions to the advantage of all shareholders. Additionally, we are positioned to source deals through our sponsor or their affiliates, enhancing our capacity to realize our strategic objectives. We believe we have the following key competitive strengths. --- While we intend to conduct a global search for target businesses without being limited by geographic region and our executive officers have experience investing in and building businesses in the Asia Pacific region and have a deep understanding of the region’s business environment, regulations, regulatory bodies and culture. We will not undertake our initial business combination with any company being based in or having the majority of the company’s operations in Greater China (which includes, solely for the purpose of this prospectus Hong Kong, Taiwan and Macau). --- Our principal executive office is located at Suite 1165-L, 3 Coleman Street #03-24, Singapore 179804, and our telephone number is +65 9488 4425.